ClinicalTrials.gg
Sign In

Endotoxemia clinical trials

The registry lists 81 studies for Endotoxemia across more than 10 countries. 7 are recruiting or about to start. 41 of them are mainly about Endotoxemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-13.

Get an email when these change. Save the Endotoxemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
60
Recruiting
6
Status unknown
6
Terminated
3
Active, not recruiting
2
Temporarily not available
1

Phase

Phase 4
7
Phase 1
7
Phase 2
4
Phase 3
1

Where

Netherlands
21
United States
11
Denmark
10
Austria
8
Canada
5
France
4

Who runs them

Radboud University Medical Center (21) · University of Aarhus (5) · Spectral Diagnostics (US) Inc. (4) · Laval University (4) · Rigshospitalet, Denmark (4) · Ohio State University (4) · Medical University of Vienna (3) · University of Vienna (3)

What is being tested here

Drugs under test in Endotoxemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexamethasone101
Tocilizumab101
Interleukin 1 Receptor Antagonist Protein101
Whey Proteins004
Cranberry002
Lipopolysaccharides002
Complement C1 Inhibitor Protein012
Rifaximin002
Green Tea Extract001
Myrciaria dubia001

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 6 Endotoxemia studies recruiting now, 2 (33%) set no upper age limit and 3 (50%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 1 (17%) for men only; 4 (67%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
100 (0%)0 (0%)
185 (83%)6 (100%)
305 (83%)6 (100%)
405 (83%)5 (83%)
503 (50%)3 (50%)
653 (50%)3 (50%)
753 (50%)3 (50%)
852 (33%)2 (33%)

Across all 81 studies, recruiting or not: 75% stop at 75 or younger and 65% at 65; 1% take children; 1% are for women only and 44% for men only; 74% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Endotoxemia studies take

Of 31 interventional studies with no phase under Endotoxemia, half reached primary completion within 17 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase17 mo8–26 · 31 studies—17 mo8–25 · 29 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 81. Browse all 81 → or search them.